title: Fulminant hepatic failure necessitating transplantation following the initiation of infliximab therapy: a cautionary tale times two.
authors.affiliation: Department of Surgery, University of Alberta, Edmonton, AB, Canada.
authors.forename: Bradley W
authors.initials: BW
authors.lastname: Rowe
authors.forename: Boris
authors.initials: B
authors.lastname: Gala-Lopez
authors.forename: Corey
authors.initials: C
authors.lastname: Tomlinson
authors.forename: Safwat
authors.initials: S
authors.lastname: Girgis
authors.forename: James A M
authors.initials: JA
authors.lastname: Shapiro
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000150:complications; D005260:Female; D016575:Hidradenitis / Q000150:complications; D006801:Humans; D000069285:Infliximab; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab